Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 6.958\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a COCCn1c(C)cc(C(=O)COC(=O)c2ccc([N+](=O)[O-])o2)c1C
b Cn1ccnc1SCC(=O)Nc1cccc([N+](=O)[O-])c1
Answer: b. Cn1ccnc1SCC(=O)Nc1cccc([N+](=O)[O-])c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cn1ccnc1SCC(=O)Nc1cccc([N+](=O)[O-])c1
Cn1ccnc1SCC(=O)Nc1cccc([N+](=O)[O-])c1
[3-[[2-(1-methylimidazol-2-yl)sulfanylacetyl]amino]phenyl]-oxido-oxoazanium